sk&f-38393 has been researched along with amphotericin b in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brooks, DP; Koster, PF; Nichols, AJ; Ruffolo, RR | 1 |
Brooks, DP; Mitchell, MP; Nichols, AJ; Ruffolo, RR; Short, BG | 1 |
Gomes, P; Soares-Da-Silva, P | 1 |
3 other study(ies) available for sk&f-38393 and amphotericin b
Article | Year |
---|---|
Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphotericin B; Animals; Creatinine; Dogs; Dopamine Agents; Female; Fenoldopam; Kidney Diseases; Male; Receptors, Dopamine; Renal Circulation | 1992 |
Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphotericin B; Animals; Benzazepines; Carbamates; Creatinine; Diuresis; Dogs; Fenoldopam; Kidney; Kidney Tubules; Male; Natriuresis; Prodrugs | 1991 |
D2-like receptor-mediated inhibition of Na+-K+-ATPase activity is dependent on the opening of K+ channels.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphotericin B; Animals; Antifungal Agents; Cardiotonic Agents; Cell Line; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Glyburide; GTP-Binding Protein alpha Subunits, Gi-Go; Hypoglycemic Agents; Ion Channel Gating; Kidney; Opossums; Pertussis Toxin; Pinacidil; Potassium Channels; Quinolines; Receptors, Dopamine D2; Sodium; Sodium-Potassium-Exchanging ATPase; Sulpiride; Vasodilator Agents; Virulence Factors, Bordetella | 2002 |